Polymorphonuclear leucocyte respiratory burst activity correlates with serum zinc level in type 2 diabetic patients with foot ulcers

British Journal of Biomedical Science

Volumn 64, Issue 1, 2007, Pages 13-17

  Larijani, Bagher ^a,c   Shooshtarizadeh, P ^a   Mosaffa, N ^b   Heshmat, R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Diabetic foot; Neutrophil activation; Respiratory burst; Zinc

Indexed keywords

ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOT ULCER; HUMAN; MALE; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESPIRATORY BURST; STATISTICAL ANALYSIS; ZINC BLOOD LEVEL;

EID: 34250741314     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732749     Document Type: Article

References (39)

1. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26: 259-65.
2. Llorente L, De La FH, Richaud-Patin Y et al. Innate immune response mechanisms in non-insulin-dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett 2000; 74: 239-44.
3. Inoue S, Lan Y, Muran J, Tsuji M. Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res Clin Pract 1996; 33: 119-27.
4. Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109: 33-44.
5. Ortmeyer J, Mohsenin V. Inhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils. Life Sci 1996; 59: 255-62.
6. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29-34.
7. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992; 15: 256-60.
8. Shah SV, Wallin JD, Eilen SD. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 1983; 57: 402-9.
9. Wierusz-Wysocka B, Wysocki H, Siekierka H, Wykretowicz A, Szczepanik A, Klimas R. Evidence of polymorphonuclear neutrophil (PMN) activation in patients with insulin-dependent diabetes mellitus. J Leukoc Biol 1987; 42: 519-23.
10. Kantar A, Wilkins G, Swoboda B et al. Alterations of the respiratory burst of polymorphonuclear leukocytes from diabetic children. A chemiluminescence study. Acta Paediatr Scand 1990; 79: 535-41.
11. Nath N, Chari SN, Rathi AB. Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 1984; 33: 586-9.
12. Ohmori M, Harada K, Kitoh Y, Nagasaka S, Saito T, Fujimura A. The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy. Life Sci 2000; 66: 1861-70.
13. Zozulinska DA, Wierusz-Wysocka B, Wysocki H, Majchrzak AE, Wykretowicz A. The influence of insulin-dependent diabetes mellitus (IDDM) duration on superoxide anion and hydrogen peroxide production by polymorphonuclear neutrophils. Diabetes Res Clin Pract 1996; 33: 139-44.
14. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
15. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a 'causal' antioxidant therapy. Diabetes Care 2003; 26: 1589-96.
16. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction. Diabetes Obes Metab 2002; 4: 224-38.
17. DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutr 2000; 130: 1509S-1511S.
18. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998; 17: 109-15.
19. Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM. Lipid peroxidation in insulin-dependent diabetic patients with early retinal degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 1995; 49: 282-8.
20. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 212-8.
21. Niewoehner CB, Allen JI, Boosalis M, Levine AS, Morley JE. Role of zinc supplementation in type II diabetes mellitus. Am J Med 1986; 81: 63-8.
22. Salgueiro MJ, Zubillaga M, Lysionek A et al. Zinc as an essential micronutrient: a review. Nutr Res 2000; 20: 737-55.
23. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990; 8: 281-91.
24. Benoni G, Cuzzolin L, Marrella M et al. Neutrophil behavior following exposure to in vivo or in vitro zinc in normal and acutely-inflamed rats: studies on lysozyme secretion, superoxide anion release and platelet adhesion. Inflammation 1998; 22: 175-89.
25. Huggett AS, Nixon DA. Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet 1957; 273 (6991): 368-70.
26. Schifreen RS, Hickingbotham JM, Bowers GN Jr. Accuracy, precision, and stability in measurement of hemoglobin A1C by 'high-performance' cation-exchange chromatography. Clin Chem 1980; 26: 466-72.
27. Venuprasad K, Parab P, Prasad DV et al. Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression. Eur J Immunol 2001; 31: 1536-43.
28. Segal AW. Nitroblue-tetrazolium tests. Lancet 1974; 2: 1248-52.
29. Jirkovska A, Fejfarova V, Hosova J, Kalanin J, Striz I, Skibova J. Non-specific immune responses in patients with chronic diabetic foot syndrome and chronic bacterial infection. Vnitr Lek 2002; 48: 142-6.
30. Yonem A, Cakir B, Guler S, Azal OO, Corakci A. Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab 2001; 3: 332-7.
31. Uchimura K, Nagasaka A, Hayashi R et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complications 1999; 13: 264-70.
32. Collier A, Rumley A, Rumley AG et al. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992; 41: 909-13.
33. Balasoiu D, van Kessel KC, Kats-Renaud HJ, Collet TJ, Hoepelman AI. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 1997; 20: 392-5.
34. Fuller CJ, Agil A, Lender D, Jialal I. Superoxide production and LDL oxidation by diabetic neutrophils. J Diabetes Complications 1996; 10: 206-10.
35. Tauber AI. Protein kinase C and the activation of the human neutrophil NADPH-oxidase. Blood 1987; 69: 711-20.
36. Karahan SC, Deger O, Orem A et al. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin Chem Lab Med 2001; 39: 109-15.
37. Hasegawa H, Suzuki K, Nakaji S, Sugawara K. Effects of zinc on the reactive oxygen species generating capacity of human neutrophils and on the serum opsonic activity in vitro. Luminescence 2000; 15: 321-7.
38. Gavella M, Lipovac V, Car A. In vitro effect of zinc on superoxide anion production by polymorphonuclear leukocytes of diabetic patients. Acta Diabetol 2000; 37: 135-7.
39. Peretz A, Cantinieaux B, Neve J, Siderova V, Fondu P. Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases. J Trace Elem Electrolytes Health Dis 1994; 8: 189-94.